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I. Purpose
Under the NIH Guidelines for Research Involving Recombinant or Synthetic DNA Molecules
(NIH Guidelines), each institution conducting or sponsoring recombinant or synthetic nucleic
acid research covered by these Guidelines is responsible for ensuring that the research is
carried out in full conformity with the provisions of the Guidelines.
The institution must establish and implement policies that provide for the safe conduct of
recombinant or synthetic nucleic acid research and ensure compliance with the Guidelines. The
institution must also establish an Institutional Biosafety Committee (IBC) whose responsibilities
need not be restricted to recombinant or synthetic nucleic acids. If the institution is engaged in
recombinant or synthetic nucleic acid research requiring biosafety level-3 (BL-3) or higher
containment or is engaged in large-scale (greater than 10 liters of culture media) research, it
must appoint a Biological Safety Officer (BSO) who shall be a member of the IBC.
II. Policy Statement
The Georgia Southern University (GS) Institutional Biosafety Committee (IBC) is a committee
appointed by the Institutional Official. The Institutional Official exercises administrative and
operational authority to commit institutional resources, enforce policies, authorize necessary
administrative or legal action, and otherwise ensure that UNH maintains strong and effective
compliance programs. As required by the NIH Guidelines, GS IBC oversees and regulates all
research with biohazardous agents and recombinant DNA molecules for research conducted by
GS faculty, staff, or students. The IBC has the authority and obligation to stop any activity using
biological materials, including but not limited to recombinant DNA and infectious organisms that
the committee believes to be unsafe.
It is the policy of the University that all activities involving potential biohazards be conducted in a
safe manner in order to protect laboratory workers, students, other persons, our community, and
the environment from potentially biohazardous agents and in such a manner that projects
conducted by one faculty member will not have an adverse effect on adjacent projects
conducted by other scientists.
The IBC oversees and establishes University policy for review and approval of all activities
involving the use of recombinant DNA and potentially biohazardous materials to assure
compliance with current regulations and guidelines. PIs and/or laboratory supervisors at GS
who either store or carry out research or diagnostic activities involving potentially biohazardous
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materials must inform the Institutional Biosafety Committee by submitting a Biosafety Protocol
approval application and receiving approval prior to beginning the project.
Further, it is University policy that no Risk Group (RG) 4 Agents may be used or stored at GS.
No activity requiring BSL4 containment may be conducted in a GS facility. See the NIH
Guidelines and CDC BMBL for a list of these agents and definitions.
III. Exclusions
There are no exclusions to this policy.
IV. Procedures
Procedures for the application, review and governance of the Institutional Biosafety Committee
are located on the Office of Research Integrity website.
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